Mar 7, 2023 | Ad-hoc, Featured news, Finance, News, Press
Group sales rise to 531.7 million by + 5.7% against previous year. EBITDA at CHF 160.5 million (+2.0%) with a margin of 30.2%. Operating income EBIT at CHF 127.2 million (-1.3%) with a margin of 23.9%. Total investments of CHF 142.6 million and creation of 141 new...
Are you ready to dive into the fascinating universe of peptides and oligonucleotides?
Sign up for our newsletter and receive the latest updates directly in your inbox.
"*" indicates required fields